147 results match your criteria: "Weill Cornell Institute of Geriatric Psychiatry[Affiliation]"
Clin Gerontol
December 2024
Weill Cornell Medicine, Division of Geriatrics and Palliative Medicine, New York, New York, USA.
Objectives: Our understanding of elder abuse (EA) phenomena has largely been shaped from the perspective of researchers and professionals whose conceptualizations often differ from the perceptions of older adults who experience mistreatment. This study sought to understand the most distressing aspects of EA victimization from the perspective of survivors.
Methods: Using a descriptive phenomenological approach, individual interviews were conducted with a diverse sample ( = 32) of EA survivors, recruited from EA support and Adult Protective Services programs in New York City and Los Angeles.
Hum Brain Mapp
December 2024
Department of Psychology, Northeastern University, Boston, Massachusetts, USA.
Diffusion-weighted imaging (DWI) has been frequently used to examine age-related deterioration of white matter microstructure and its relationship to cognitive decline. However, typical tensor-based analytical approaches are often difficult to interpret due to the challenge of decomposing and (mis)interpreting the impact of crossing fibers within a voxel. We hypothesized that a novel analytical approach capable of resolving fiber-specific changes within each voxel (i.
View Article and Find Full Text PDFAm J Geriatr Psychiatry
December 2024
Weill Cornell Institute of Geriatric Psychiatry (NS, LWV, ZM, GSA, FMG), Weill Cornell Medicine, White Plains, NY.
Background: The course of late-life depression is associated with functioning of multiple brain networks. Understanding the brain mechanisms associated with response to psychotherapy can inform treatment development and a personalized treatment approach. This study examined how activation of key regions of the salience network, default mode network and reward systems is associated with response to psychotherapies for late-life depression.
View Article and Find Full Text PDFAm J Geriatr Psychiatry
November 2024
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, 21 Bloomingdale Road, White Plains, NY 10605. Electronic address:
Sensors (Basel)
October 2024
Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medical College, New York, NY 10065, USA.
Recent advancements in mobile health (mHealth) technology and the ubiquity of wearable devices and smartphones have expanded a market for digital health and have emerged as innovative tools for data collection on individualized behavior. Heterogeneous levels of device usage across users and across days within a single user may result in different degrees of underestimation in passive sensing data, subsequently introducing biases if analyzed without addressing this issue. In this work, we propose an unsupervised 2-Stage Pre-processing Algorithm for Passively Sensed mHealth Data (2SpamH) algorithm that uses device usage variables to infer the quality of passive sensing data from mobile devices.
View Article and Find Full Text PDFNeuropsychopharmacology
December 2024
Department of Psychiatry, Weill Cornell Medicine, New York, NY, USA.
Post-COVID-19 cognitive deficits are common, persistent, and disabling. Evidence on effective treatments is limited. The goal of this study was to investigate the efficacy of a digital intervention to reduce cognitive and functional deficits in adults with persistent post-COVID-19 cognitive dysfunction.
View Article and Find Full Text PDFAm J Geriatr Psychiatry
December 2024
Department of Psychiatry, Weill Cornell Institute of Geriatric Psychiatry (GSA), Weill Cornell Medicine, 21 Bloomingdale Road, White Plains, NY. Electronic address:
Psychiatry Res
December 2024
Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Centre for Mental Health, University Health Network, Toronto, Ontario, Canada.
Little is known about factors that contribute to attrition in clinical trials of the pharmacotherapy of psychotic depression. The purpose of this study was to identify factors associated with attrition during acute pharmacotherapy in the Study of the Pharmacotherapy of Psychotic Depression II (STOP-PD II) clinical trial. Sociodemographic and clinical variables were assessed at baseline in 269 men and women, aged 18-85 years, who were treated with up to 12 weeks of open-label sertraline plus olanzapine.
View Article and Find Full Text PDFAm J Geriatr Psychiatry
December 2024
Weill-Cornell Institute of Geriatric Psychiatry, New York, NY, USA. Electronic address:
J Affect Disord
October 2024
Center for Cognitive Medicine, Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN, USA; Geriatric Research, Education, and Clinical Center, Veterans Affairs Tennessee Valley Health System, Nashville, TN, USA. Electronic address:
Background: Late-life depression (LLD) is characterized by a poor response to antidepressant medications and diminished cognitive performance, particularly in executive functioning. There is currently no accepted pharmacotherapy for LLD that effectively treats both mood and cognitive symptoms. This study investigated whether transdermal nicotine augmentation of standard antidepressant medications benefitted mood and cognitive symptoms in LLD.
View Article and Find Full Text PDFAm J Geriatr Psychiatry
June 2024
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, NY. Electronic address:
Int Psychogeriatr
January 2024
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, NY, USA.
Psychother Res
December 2023
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, NY, USA.
Objective: There is a lack of evidence-based scalable therapies for elder abuse victims, with no current remotely delivered tailored psychotherapy. The purpose of this manuscript is to (a) examine the effectiveness of a brief therapy for depression for elder abuse victims, and (b) to compare remote intervention delivery via phone or video to the traditional in-person delivery.
Method: PROTECT, , is a brief therapy developed in collaboration with partners at the Department for the Aging (DFTA) of New York City.
Am J Geriatr Psychiatry
February 2024
Weill Cornell Medicine (VMW, DNK), Weill-Cornell Institute of Geriatric Psychiatry, White Plains, NY. Electronic address:
Psychol Med
April 2024
Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
Background: Remitted psychotic depression (MDDPsy) has heterogeneity of outcome. The study's aims were to identify subgroups of persons with remitted MDDPsy with distinct trajectories of depression severity during continuation treatment and to detect predictors of membership to the worsening trajectory.
Method: One hundred and twenty-six persons aged 18-85 years participated in a 36-week randomized placebo-controlled trial (RCT) that examined the clinical effects of continuing olanzapine once an episode of MDDPsy had remitted with sertraline plus olanzapine.
Am J Geriatr Psychiatry
March 2024
SP Tobin and AM Cooper Professor Emeritus (GSA), DeWitt Wallace Distinguished Scholar, Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, NY. Electronic address:
Psychiatry Res
November 2023
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, New York, NY, USA. Electronic address:
Psychotherapies are effective in reducing late-life depression. Yet, about half of patients remain depressed at treatment end. Advances in neuroscience can inform simplified interventions that target key brain networks impacted by depression.
View Article and Find Full Text PDFAm J Geriatr Psychiatry
November 2023
Weill Cornell Institute of Geriatric Psychiatry (FMG), Weill Cornell Medicine, New York, NY.
BMC Health Serv Res
June 2023
Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, 402 East 67th Street, New York, NY, 10065, USA.
Background: A significant number of late middle-aged adults with depression have a high illness burden resulting from chronic conditions which put them at high risk of hospitalization. Many late middle-aged adults are covered by commercial health insurance, but such insurance claims have not been used to identify the risk of hospitalization in individuals with depression. In the present study, we developed and validated a non-proprietary model to identify late middle-aged adults with depression at risk for hospitalization, using machine learning methods.
View Article and Find Full Text PDF